Erhan Gökmen

7PUBLICATIONS
108CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2026
DUSP29 does not regulate melanoma-myoblast interactions in a skeletal muscle co-culture model.

Sercan Ön, Harika Atmaca İlhan, Damla Günenç

|Dec 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Büşra Bülbül, Bekir Ucun, Can Cangür

|Oct 29, 2025
Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Buket Şahin Çelik, Aslı Geçgel, Oğuzcan Özkan

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Oct 05, 2023
Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization.

Çağlar Ünal, Tolga Özmen, Çetin Ordu

|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.

Aykut Bahçeci, Semra Paydaş, Naziye Ak

Pageof 2

Frequent Collaborators

2 joint publications

Gülcan Bulut

2 joint publications

Şaziye Burçak Karaca Yayla

2 joint publications

Cengiz Karaçin

2 joint publications

Oğuzcan Özkan